Identification of two novel mutations in non-Jewish factor XI deficiency. 1995

Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
MRC Clinical Sciences Centre, Royal Postgraduate Medical School, London.

We have studied two heterozygous unrelated CRM- non-Jewish FXI-deficient patients. Neither of the patients carries a previously described mutation. Their FXI genes were screened by SSCP analysis following PCR amplification of each exon and the flanking intronic sequences. DNA fragments showing aberrant mobility were cloned and sequenced. The following mutations were identified: in case 1, a T to G transition in exon 12 results in the substitution of Phe-442 by Val (FXI-F442V); in case 2 a C to A transition in exon 5 results in the substitution of Cys-128 by a nonsense codon (FXI-C128X). The missense mutation results in a substitution within the protease domain of FXI. Molecular modelling locates this residue in a structurally conserved region of the protease domain and the amino acid substitution may therefore interfere with either chain folding and subsequent secretion or the stability of the protein in plasma. We conclude that the mutations which we have identified are responsible for the inherited abnormality in these patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005172 Factor XI Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C. Coagulation Factor XI,Plasma Thromboplastin Antecedent,Blood Coagulation Factor XI,Factor 11,Factor Eleven,Antecedent, Plasma Thromboplastin,Factor XI, Coagulation,Thromboplastin Antecedent, Plasma

Related Publications

Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
September 2010, Haemophilia : the official journal of the World Federation of Hemophilia,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
January 1999, British journal of haematology,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
January 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
October 2003, American journal of hematology,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
March 2003, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
August 2003, American journal of hematology,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
August 2020, International journal of hematology,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
October 2007, Haematologica,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
December 1999, British journal of haematology,
Y Imanaka, and K Lal, and T Nishimura, and P H Bolton-Maggs, and E G Tuddenham, and J H McVey
January 2023, Acta haematologica,
Copied contents to your clipboard!